Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 10,963,855
- Share change
- +394,176
- Total reported value
- $60,850,000
- Price per share
- $5.55
- Number of holders
- 12
- Value change
- +$2,123,813
- Number of buys
- 7
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420P308:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.6%
|
9,207,012
|
$72,643,000 | — | 31 Mar 2018 | |
| Park West Asset Management LLC |
13F
|
Company |
0.9%
|
1,258,733
|
$9,646,000 | — | 31 Mar 2018 | |
| Bruce & Co., Inc. |
13F
|
Company |
—
class O/S missing
|
296,172
|
$2,336,000 | — | 31 Mar 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
40,248
|
$318,000 | — | 31 Mar 2018 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.02%
|
27,606
|
$218,000 | — | 31 Mar 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.01%
|
15,784
|
$125,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
11,270
|
$89,000 | — | 31 Mar 2018 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,841
|
$30,000 | — | 31 Mar 2018 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
3,474
|
$27,000 | — | 31 Mar 2018 | |
| Winslow, Evans & Crocker, Inc. |
13F
|
Company |
0%
|
1,258
|
$9,926 | — | 31 Mar 2018 | |
| First Horizon Advisors, Inc. |
13F
|
Company |
0%
|
333
|
$2,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
120
|
$1,000 | — | 31 Mar 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
97
|
$1,000 | — | 31 Mar 2018 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q2 2018
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.